Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDNF Protéine

CDNF Origine: Humain Hôte: CHO Cells Recombinant WB, SDS, CC, in vivo Active
N° du produit ABIN1405917
  • Antigène Voir toutes CDNF Protéines
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Origine
    • 4
    • 4
    • 2
    Humain
    Source
    • 7
    • 2
    • 1
    CHO Cells
    Application
    Western Blotting (WB), SDS-PAGE (SDS), Cell Culture (CC), In vivo Studies (in vivo)
    Attributs du produit
    Biological properties: Protein is biologically active. Suitable for cell culture and in vivo testing. Biological activity of human CDNF was tested in rat 6-OHDA model of Parkinson’s disease and shown to be both neuroprotective and neurorestorative (for methods see: Lindholm et al. 2007, Voutilainen et al. 2011)
    Purification
    Purified by ion-exchange chromatography and gel-filtration from serum-free CHO growth media.
    Protein is sterile-filtrated through 0.22 µg filter.
    Purified human CDNF is characterized as homogenous material by mass-spectroscopy.
    niveau d'endotoxine
    Less than 1EU/µg of protein as determined by LAL method
    Top Product
    Discover our top product CDNF Protéine
  • Commentaires

    Synonyms: Cerebral dopamine neurotrophic factor - CDNF, ARMETL1.

    Restrictions
    For Research Use only
  • Concentration
    1 mg/ml Concentration of the protein is determined by BCA Protein Analysis kit (Pierce). BSA was used as a standard
    Buffer
    PBS pH 7.5
    Conseil sur la manipulation
    Recommended to aliquot into smaller quantities. Avoid repeated freeze-thaw cycles.
    Stock
    -80 °C
  • Antigène
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Autre désignation
    CDNF (CDNF Produits)
    Synonymes
    ARMETL1 Protein, 9330140G23 Protein, Armetl1 Protein, cerebral dopamine neurotrophic factor Protein, CDNF Protein, Cdnf Protein
    Sujet
    CDNF is a trophic factor for midbrain dopamine neurons in vivo. It prevents the 6-OHDA- (Lindholm et al. 20007, Voutilainen et al., 2011) and MPTP-induced degeneration (Airavaara et al., 2012) of dopamine neurons in rodent models of Parkinson’s disease. When administered after 6-OHDA or MPTP –lesioning it restores the dopaminergic function and prevents degeneration of dopamine neurons in substantia nigra pars compacta.
    Poids moléculaire
    Approximately 18.5 kDa, a single non-glycosylated polypeptide chain containing 163 amino acids.
    UniProt
    Q49AH0
Vous êtes ici:
Support technique